Click here to read the previous top cannabis stocks year-to-date list.

Cannabis investments have seen an upswing in momentum to start 2021. As the first quarter wraps up, the Investing News Network looks at the top cannabis stocks in terms of share price performance and what their activity says about the space as a whole at the moment.

Despite the current positivity, the cannabis sector has shown its fair share of volatility, a trait experts have said will likely not go away anytime soon. So far this year, key mergers and acquisitions have affected the performance of some names, while steady results have helped boost others.

Data for this top cannabis stocks article was collected on April 23, 2021, and the companies included had to meet a minimum market cap requirement of C$10 million. Cannabis companies on the NYSE, NASDAQ, TSX, TSXV and CSE were considered.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

1. GTEC Holdings (TSXV:GTEC,OTCQB:GGTTF)

Year-to-date gain: 484.62 percent; current market cap: C$149.28 million; current share price: C$0.75

GTEC Holdings is a Canadian operator of cannabis facilities and branded products. This year, the company has cleaned house with a convertible debt repayment and a new C$23 million bought deal.

In terms of upside for this financial period, the company announced a new export agreement with Focus Medical Herbs, an Israeli medical cannabis company that holds a partnership with IM Cannabis (NASDAQ:IMCC).

“With the signing of this deal, GTEC will become an up-and-coming player within the global cannabis market, while continuing to drive significant incremental revenues and gross margin,” Michael Blady, co-founder and vice president of GTEC, told investors.

2. Experion Holdings (TSXV:EXP,OTCQB:EXPFF)

Year-to-date gain: 244.44 percent; current market cap: C$35.29 million; current share price: C$0.36

This company manages Experion Biotechnologies, a licensed cannabis producer based in BC that produces the popular Citizen Stash line of products.

As part of its 2021 outlook notice to investors, the company said it believes its flagship brand plays well with current consumer demand for low-cost products while retaining a premium brand appeal.

In mid-March, Experion secured its first end-to-end pre-roll manufacturing and product distribution services manufacturing agreement with the Valens Company (TSX:VLNS,OTCQX:VLNCF).

Jarrett Malnarich, CEO of Experion, said the new two year business partnership will help the company expand customer access to Citizen Stash.

3. The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF)

Year-to-date gain: 129.41 percent; current market cap: C$278.54 million; current share price: C$0.37

The Supreme Cannabis Company celebrated one last push of gains as it begins to head into the sunset. In early April, it was announced that Canopy Growth (NASDAQ:CGC,TSX:WEED) will be stepping in to acquire Supreme Cannabis entirely.

“Combining Supreme Cannabis with Canopy — a Canadian market leader with exposure to the United States — presents a significant value creation opportunity for both companies,” Beena Goldenberg, president and CEO of Supreme, said in a statement to investors.

The deal is expected to embolden the brand catalogue for Canopy Growth and should offer a significant bonus to the trading activity of Supreme holders. The company saw a double-digit boost in the wake of the acquisition deal announcement.

The other major spike for Supreme this year was seen leading up to the release of the firm’s financial report for the period ended on December 31, 2020.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

4. Next Green Wave Holdings (CSE:NGW,OTCQX:NXGWF)

Year-to-date gain: 108.11 percent; current market cap: C$128.91 million; current share price: C$0.72

Amid all the volatility present in the cannabis industry, Next Green Wave Holdings has shown its investors a steady growth path.

During the Q1 period, the company celebrated 12 consecutive months of profitability and was included in the OTCQX Best 50 list, showing its track record against all companies on OTC exchanges.

As part of its Q4 2020 report, shared in January, CEO Michael Jennings said 2020 was a transformational year for the company with a consistent performance.

“Moving into 2021, we want to build on that momentum through expansion,” Jennings said as Next Green Wave announced the buildout of an additional 50,000 square foot indoor cultivation facility within its existing Coalinga campus. The firm expects it to be active later in the year.

5. Aphria (NASDAQ:APHA,TSX:APHA)

Year-to-date gain: 93.70 percent; current market cap: C$5.81 billion; current share price: C$18.11

Aphria has had a busy 2021 so far. After announcing a blockbuster merger transaction with fellow cannabis producer Tilray (NASDAQ:TLRY) in December 2020, the firm has been racing towards finishing the transaction.

In mid-April, Aphria holders voted in favor of the overall deal with Tilray.

“We appreciate their support, as we believe the business combination will create a Combined Company with a strong financial profile, low-cost production, market share leading brands, distribution network and unique partnerships,” Irwin Simon, Aphria chairman and CEO, said.

During this period, shareholders of Aphria have had the chance to take a closer look at the finances of the company on two separate occasions — the firm released Q2 and Q3 results for the 2021 fiscal year in January and April, respectively.

Investor takeaway

Cannabis companies have been able to weather the turbulent difficulties of 2020 and have now set a course for expansion and steady growth thanks to the projections attached to the US marketplace and its potential regulation efforts.

So far in 2021, cannabis investments have still shown vulnerability to volatility, but at the same time investors will have to remember that more often than not, that is par for the course with this sector.

Looking ahead, investors will need to look at how US plans may alter the performance of the entire cannabis stock space and produce the next batch of top cannabis stocks for the year.


INNdepth

Want more details? Check out these articles for more INNdepth coverage:

Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry.


Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

US cannabis received a boost this week with a policy move that may hint at future changes.

Meanwhile, Amazon (NASDQ:AMZN) threw its full support behind cannabis reform in the US by way of a public post confirming the company’s acceptance of the drug.

Keep reading... Show less
  • Research findings originated from cannabinoid-based collaboration with leading epilepsy researcher, Dr. Peter Carlen, at UHN that is also supported by a Mitacs Accelerate program grant.
  • Avicanna’s proprietary formulation showed promising pre-clinical results in reducing seizures and will be developed through the company’s pharmaceutical development pipeline as an epilepsy drug candidate.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals is pleased to announce that it has filed a provisional patent application with the United States Patent and Trademark Office, entitled “Methods for Reducing or Eliminating Incidence of Seizures and Sudden Unexpected Death in Epilepsy”, on the use of a novel cannabinoid formulation (the “ Formulation Candidate ”).

Keep reading... Show less

Cannabis legalization in Canada helped kickstart a financial revolution in the stock market with the launch of a diverse portfolio of marijuana firms.

With the boom of public cannabis businesses in full swing, are you thinking about investing in cannabis companies? If so, consider starting your journey here.

A wide spectrum of marijuana stocks have made their mark in the global industry thanks to the amount of money raised from investors and the attention the sector is getting from established industries.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

What’s to come is anyone’s guess, but it seems this new and burgeoning industry is still in its early days, with diverse nations beginning to move forward with plans for legalizing marijuana.

That means there’s likely still money to be made in cannabis stocks as the market builds and cannabis products expand in availability over the next few years.

There are many differing opinions about how much the global legal cannabis market will be worth in the years to come, with estimates including US$70.6 billion by 2028 and US$91.5 billion by that same year.

But one thing is almost certain: The market is set to grow as opinions surrounding the plant evolve over time and as platforms crop up to supply different consumption preferences. And all of that will mean more cannabis investment opportunities with both existing companies and future entries to the market.

For now, let’s take a look at where you can invest your money at this point in time.

How to invest in cannabis: Canadian cannabis stocks

First thing’s first: Canada. This is the obvious place to start as marijuana is legal at the federal level and Canadian cannabis stocks are less likely than their US counterparts to suffer from political volatility.

That said, due to the uncertainty of investing in the US marijuana space, where the drug is not legal at the federal level, Canadian firms have been forced to make choices about how they operate. For example, Canada’s senior exchanges do not allow companies with American cannabis assets to list.

While the Canadian cannabis space continues to face challenges, investors are eagerly watching as companies move into the edibles and beverages markets and develop new products.

For lists of Canadian marijuana stocks to consider, click here.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

How to invest in cannabis: US cannabis stocks

Although some US states have legalized cannabis, American cannabis stocks may be riskier than those in Canada due to federal restrictions on the sale and cultivation of cannabis.

However, as the saying goes, the greater the risk, the greater the possible reward. The US market could grow up to US$43 billion by 2025, and that’s not even including the size of the market if nationwide legalization happens. It’s easy to see that US cannabis stocks could inherit a huge chunk of the pie if federal law finally legalizes the commodity.

All in all, picking the right US cannabis stocks could mean massive gains if the plant is ultimately legalized federally. It’s worthwhile for investors to do their research and to be aware of the risks and potential benefits involved in investing in the space.

For a list of US cannabis stocks to consider, click here.

How to invest in cannabis: A side note

Many companies in the cannabis space have begun to veer in one direction or another.

For example, some of the largest marijuana producers have moved towards deals with beverage or pharmaceutical companies for the production of novel new products. Others in the space continue to pursue innovation in the recreational market.

The beverage side in particular has seen interest from companies, with cannabis firms partnering with brew businesses. One example is Canopy Growth (NYSE:CGC,TSX:WEED), which has teamed up with Constellation Brands (NYSE:STZ), a leading producer in the alcoholic beverage industry.

It’s important to be aware that each niche has its own possibilities and challenges. For instance, while many market participants are convinced of the promise in beverages, these drinks have been hampered by strict marketing rules, among other factors.

Another aspect to consider is whether to pursue big caps or small caps. That has a lot to do with personal comfort. While big caps are often regarded as more stable than small caps, in the cannabis industry there’s been considerable volatility.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

How to invest in cannabis: Cannabis ETFs

If you really know your cannabis companies, then you could enjoy larger gains by simply investing in those specific firms. However, if you aren’t overly familiar with the cannabis space or you are new to it, it could be a good idea to check out the cannabis exchange-traded funds (ETFs) available.

A cannabis ETF gives you exposure to several different cannabis stocks and takes the guesswork out of cherry picking which stock to bet on. One issue with ETFs is that like any other group dynamic, if one stock drops off it brings the whole fund down proportionally with it. Of course, the opposite is also true.

Recently investors have seen the addition of new ETFs offering exposure to the US market, including firms with entries into the hemp space, thanks to the sales of CBD products.

For a list of cannabis ETFs to consider, click here.

How to invest in cannabis: Final thoughts

No matter which way you slice it — or grind it, in this case — the cannabis market is an exciting business to invest in right now. Whether you invest in cannabis ETFs or Canadian or US marijuana stocks, or if you’re still waiting on the sidelines for more maturity from the types of cannabis companies trading, this industry is one to watch, and one that looks like it’ll keep climbing in the future.

Keep reading... Show less

TransCanna (CSE: TCAN) (FSE: TH8) (“the Company”) is pleased to announce that plants are going into its first crop management site today – a greenhouse in Wesley, California.

The Company partnered with the 3rd generation cannabis farmers at 365 CannaFarms to consult on the construction of the state-of-the-art, computer-controlled greenhouse and to help manage the crop for the client, Central Valley Growers. The entire crop is comprised of premium genetic strains from Lyfted Farms, TransCanna‘s wholly-owned subsidiary.

Keep reading... Show less

Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced it has closed its acquisition of the Neurology Centre of Toronto (NCT), a leading Canadian provider of clinical neurologic care. The purchase agreement was previously announced on July 6, 2021 .

Keep reading... Show less